Evidence for these aspects is provided by a study using a glioma mouse model with the administration of an inhibitor of the checkpoint protein PD-L1 (programmed cell-death-ligand 1) and the administration of the ferroptosis inhibitor ferrostatin 1, either alone or in combination. Here, CD274 is linked to glioma.